Primary T Cell Lymphoma of the Testis.
- Author:
Hyung Il LEE
1
;
Hwal LEE
;
Hyug Jun CHANG
;
Tae Jung CHANG
;
Kyung Seop LEE
Author Information
1. Deparments of Urology, College of Medicine, Dongguk University, Gyeongju, Korea. ksleemd@mail.dongguk.ac.kr
- Publication Type:Case Report
- Keywords:
Lymphoma;
Testis;
Neoplasm
- MeSH:
Aged;
Drug Therapy;
Humans;
Lung;
Lymphoma;
Lymphoma, B-Cell;
Lymphoma, Non-Hodgkin;
Lymphoma, T-Cell*;
Orchiectomy;
Prognosis;
Recurrence;
Skin;
Subcutaneous Tissue;
Testicular Neoplasms;
Testis*
- From:Korean Journal of Urology
2001;42(12):1333-1335
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Primary malignant lymphoma of the testis is an uncommon tumor, accounting for only 1 to 9% of all testicular neoplasms and 1% of all non-Hodgkin's lymphoma. Especially, T cell lymphoma of the testis is very rare. However, it is the most common testicular malignancy in the elderly. It has a propensity for extranodal spread to the skin, subcutaneous tissue, CNS and lung. Immunohistochemical studies of testicular lymphoma have showed that the majority of these are B cell lymphomas, with rare reports of T cell lymphomas. Given the rarity of this disease, treatment has not been standardized. However, there is universal agreement that orchiectomy is the initial treatment. Although excellent results with a doxorubicin-containing chemotherapy regimen have been achieved in early stage disease, most patients have relapse of disease and a grave prognosis. We experienced the primary T cell lymphoma of the testis that was developed in 41 year-old-man.
